Clinical Trial Update: CyberKnife Based Hypofractionated Radiotherapy for Vertebral Hemangiomas [Phase 3]

View source ↗

Summary

Phase 3 trial update on CyberKnife-based hypofractionated radiotherapy for vertebral hemangiomas. The current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vertebral Hemangioma

Snippet

Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology | Conditions: Hemangioma of Vertebral Column | Phase 3 | Status: UNKNOWN